Exicure (NASDAQ:XCUR – Get Free Report) and NewAmsterdam Pharma (NASDAQ:NAMS – Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, dividends, institutional ownership, profitability, analyst recommendations, earnings and risk. Insider and Institutional Ownership 42.8% of Exicure shares […]
Head to Head Comparison: Exicure (NASDAQ:XCUR) and NeuBase Therapeutics (NASDAQ:NBSE)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Short Interest in Exicure, Inc (NASDAQ:XCUR) Expands By 495 9%
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
281,636 Shares in Exicure, Inc (NASDAQ:XCUR) Acquired by Carlyle Group Inc
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Exicure, Inc. (NASDAQ:XCUR – Get Free Report)’s share price shot up 2.9% during mid-day trading on Thursday . The company traded as high as $1.08 and last traded at $1.07. 19,543 shares traded hands during trading, a decline of 46% from the average session volume of 35,993 shares. The stock had previously closed at $1.04. […]